American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 547-552 , December 2009

Safety of influenza vaccination during pregnancy

  • Pranita D. Tamma, MD

      Affiliations

    • Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD
    • Corresponding Author InformationReprints: Pranita D. Tamma, MD, Department of Pediatrics Infectious Diseases, Johns Hopkins University School of Medicine, 200 N. Wolfe St., Room 3095, Baltimore, MD 21287
    • ,
  • Kevin A. Ault, MD

      Affiliations

    • Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA
    • Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA
    • ,
  • Carlos del Rio, MD

      Affiliations

    • Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA
    • Hubert Department of Global Health, Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA
    • Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA
    • ,
  • Mark C. Steinhoff, MD

      Affiliations

    • Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • ,
  • Neal A. Halsey, MD

      Affiliations

    • Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD
    • Institute for Vaccine Safety, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • ,
  • Saad B. Omer, MBBS, MPH, PhD

      Affiliations

    • Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA
    • Hubert Department of Global Health, Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA

Received 4 September 2009 ,Revised 25 September 2009 ,Accepted 29 September 2009.

References 

  1. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP) 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1–52
  2. Harris JW. Influenza occurring in pregnant women. JAMA. 1919;72:978–980
  3. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172–1175
  4. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–458
  5. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121:947–952
  6. Foster D, Talsam A, Furumoto-Dawson A, Ohmit S, Marguilies J, Arden N. Influenza vaccine effectiveness in preventing hospitalizations for pneumonia in the elderly. Am J Epidemiol. 1992;136:296–307
  7. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995;333:889–893
  8. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knotterus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661–1665
  9. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123:518–527
  10. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, US, 1989-2005. Vaccine. 2008;26:1786–1793
  11. Centers for Disease Control and Prevention. CDC advisors make recommendations for use of vaccine against novel H1N1. http://www.cdc.gov/media/pressrel/2009/r090729b.htmAccessed Sept. 2, 2009
  12. Kosmak GW. The occurrence of epidemic influenza in pregnancy. Am J Obstet. 1919;79:238–251
  13. Greenberg M, Jacobziner H, Pakter J, Weisl BA. Maternal mortality in the epidemic of Asian influenza: New York City, 1957. Am J Obstet Gynecol. 1958;76:897–902
  14. Govan ADT, Macdonald HRF. Influenza complicating heart disease in pregnancy. Lancet. 1957;2:891
  15. Deaths from Asian influenza: a report by the public health laboratory service based on records from hospital and public health laboratories. [no author listed] Br Med J. 1958;2:915–919
  16. Harper SA, Fukada K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2004;53:1–40
  17. American College of Obstetricians and Gynecologists. Influenza vaccination and treatment during pregnancy: ACOG committee opinion no. 305. Obstet Gynecol. 2004;104:1125–1126
  18. American College of Obstetricians and Gynecologists. Pandemic (H1N1) 2009 influenza. http://www.acog.org/departments/dept_notice.cfm?recno=30&bulletin=4902Accessed Sept. 2, 2009
  19. Laibl VR, Sheffield JS. Influenza and pneumonia in pregnancy. Clin Perinatol. 2005;32:727–738
  20. Longman RE, Johnson TRB. Viral respiratory disease in pregnancy. Curr Opin Obstet Gynecol. 2007;19:120–125
  21. Le S, Rubio ER, Alper B, Szerlip HM. Respiratory complications of pregnancy. Obstet Gynecol Surv. 2001;57:39–46
  22. Gaunt G, Ramin K. Immunological relationship between the mother and the fetus. Am J Perinatol. 2001;18:299–312
  23. Sridama V, Pacini F, Yang SL, Moawad A, Reily M, DeGrott LJ. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med. 1982;307:352–356
  24. Lederman MM. Cell-mediated immunity and pregnancy. Chest. 1984;86:S6–S9
  25. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis. 2008;8:44–52
  26. Schanzer DL, Langley JM, Tam TWS. Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000. J Obstet Gynecol Can. 2007;29:622–629
  27. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1988;148:1094–1102
  28. Hartert TV, Neuzil KM, Shintani AK, et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol. 2003;189:1705–1712
  29. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol. 2006;107:1315–1322
  30. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555–1564
  31. France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med. 2006;160:1277–1283
  32. Munoz FM, Greisinger AJ, Wehmanen OA, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2005;192:1098–1106
  33. Black SB, Shinefeld HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21:333–339
  34. Yeager DP, Toy EC, Baker B. Influenza vaccination in pregnancy. Am J Perinatol. 1999;16:283–286
  35. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis. 1993;168:647–656
  36. Deinard AS, Ogburn P. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am J Obstet Gynecol. 1981;140:240–245
  37. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis. 1979;140:141–146
  38. Murray DL, Imagawa DT, Okada DM, St Geme JW. Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol. 1979;10:184–187
  39. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol. 1973;2:229–235
  40. Heinonen OP, Slone D, Shapiro S. The collaborative perinatal project. In:  Kaufman DW editors. Birth defects and drugs in pregnancy. Boston, MA: Littleton Publishing Sciences Group; 1977;p. 8–14314-21
  41. Hulka JF. Effectiveness of polyvalent influenza vaccine in pregnancy: report of a controlled study during an outbreak of Asian influenza. Obstet Gynecol. 1964;23:830–837
  42. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system: VAERS working group. Vaccine. 1999;17:2908–2917
  43. Pool V, Iskander J. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2006;194:1200
  44. MacDonald NE, Riley LE, Steinhoff MC. Influenza immunization in pregnancy. Obstet Gynecol. 2009;114:365–368
  45. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31–40
  46. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med. 2002;347:2097–2103
  47. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–231
  48. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-3004. N Engl J Med. 2005;353:2559–2567
  49. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J. 1987;6:398–403
  50. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis. 1980;142:844–849
  51. Centers for Disease Control and Prevention. Influenza A (H1N1) 2009 monovalent vaccine safety monitoring: CDC planning recommendations for state, local, tribal, and territorial health officials. http://www.cdc.gov/h1n1flu/vaccination/safety_planning.htmAccessed Sept. 2, 2009
  52. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: a descriptive study. Lancet. 2002;360:1737–1741
  53. Henderson DC. Mercury in vaccines–reassuring news. Lancet. 2002;360:1711–1712
  54. Thompson WW, Price C, Goodson B, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357:1281–1292
  55. Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med. 2003;25:101–106
  56. Madsen KM, Lauritsen MB, Pedersen CB, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics. 2003;112:604–606
  57. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics. 2006;118:e139–e150
  58. Verstraeten T, Davis RL, DeStefano F, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112:1039–1048
  59. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA. 2003;290:1763–1766
  60. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;114:584–591
  61. Heron J, Golding J ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatric. 2004;114:577–583
  62. Immunization Safety Review Committee. Report of the Institute of Medicine (Immunization safety review: vaccines and autism). Washington, DC: Institute of Medicine; 2004;
  63. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Services (USPHS). [no author listed] Pediatrics. 1999;104:568–569

 Dr Tamma is supported by a National Institutes of Health (NIH) fellowship training Grant. Dr del Rio is supported by Grants from NIH (HIV vaccine trials network and vaccine treatment and evaluation units), Centers for Disease Control and Prevention (CDC), Emory Global Health Institute, Merck and Co., Inc. (West Point, PA), and Sanofi Pasteur. Dr Steinhoff is supported by the Bill and Melinda Gates Foundation, NIH, and Wyeth Vaccines. Dr Halsey is supported by Berna, Intercel, Merck (North Wales, PA), Novartis, CDC, and NIH. Dr Omer is supported by the Bill and Melinda Gates Foundation, CDC, Merck (North Wales, PA), and Emory Global Health Institute.

 Dr Omer was awarded the Maurice R. Hilleman Early-stage Career Investigator Award by the National Foundation for Infectious Diseases, funded by an unrestricted educational Grant to the National Foundation for Infectious Diseases from Merck and Co., Inc. However, Dr Omer had no direct interaction with Merck and Co., Inc. related to this award.

PII: S0002-9378(09)01108-9

doi: 10.1016/j.ajog.2009.09.034

American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 547-552 , December 2009

Article Tools